4884 Kringle Pharma, Inc. |
12/25/2024 16:55 | Analyst Report Released by Shared Research Inc. |
11/26/2024 12:30 | [Delayed]Financial Results for the Fiscal Year Ended September 30, 2024[Japanese GAAP](Non-consolidated) |
08/27/2024 17:00 | Analyst Report Released by Shared Research Inc. |
08/22/2024 15:00 | [Delayed] Financial Results for the Nine Months Ended June 30, 2024[Japanese GAAP](Non-consolidated) |
06/20/2024 16:45 | Analyst Report Released by Shared Research Inc. |
06/11/2024 15:50 | Presentation at the 2nd Annual Spinal Cord Injury Investor Symposium |
05/23/2024 11:30 | [Delayed] Financial Results for the Six Months Ended March 31, 2024[Japanese GAAP](Non-consolidated) |
03/11/2024 15:00 | Analyst Report Released by Shared Research Inc. |
02/27/2024 15:00 | [Delayed]Financial Results for the Three Months Ended December 31, 2023[Japanese GAAP](Non-consolidated) |
02/09/2024 15:40 | Topline Data from Phase 3 Study of KP-100IT in Acute Spinal Cord Injury |
01/05/2024 16:00 | Analyst Report Released by Shared Research Inc. |